Literature DB >> 8592650

Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6.

F P Bellinger1, S G Madamba, I L Campbell, G R Siggins.   

Abstract

The cytokine interleukin-6 (IL-6) may be a contributing mediator of CNS injury in several neurological disorders. To investigate the role of IL-6 in memory-related disorders, we examined transgenic mice (GFAP-IL6) with cerebral overexpression of IL-6 using paired-pulse facilitation, paired-pulse inhibition, and long-term potentiation (LTP) in an in vitro preparation. We found that paired-pulse potentiation and inhibition in the dentate gyrus of hippocampal slices prepared from the GFAP-IL6 mice did not differ significantly from age-matched control animals, suggesting that the increase in paired-pulse inhibition seen previously in in vivo studies of this model was due to alterations of afferents from other brain regions. However, LTP in the dentate was significantly reduced in slices from GFAP-IL6 transgenic mice when compared with littermate wild-type controls, providing support for a role of IL-6 in the pathogenesis of neurodegenerative associated memory-related disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592650     DOI: 10.1016/0304-3940(95)11976-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  47 in total

1.  Inflammatory pathways link socioeconomic inequalities to white matter architecture.

Authors:  Peter J Gianaros; Anna L Marsland; Lei K Sheu; Kirk I Erickson; Timothy D Verstynen
Journal:  Cereb Cortex       Date:  2012-07-06       Impact factor: 5.357

2.  Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning.

Authors:  Michael D Burton; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2011-10-29       Impact factor: 7.217

3.  Editorial: cytokine inhibition for treatment of Alzheimer's disease.

Authors:  Paul B Rosenberg
Journal:  MedGenMed       Date:  2006-04-26

4.  Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.

Authors:  Salim S El-Amouri; Hong Zhu; Jin Yu; Robert Marr; Inder M Verma; Mark S Kindy
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

Review 5.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

6.  The role of macrophage migration inhibitory factor in Alzheimer's disease.

Authors:  Michael Bacher; Oliver Deuster; Bayan Aljabari; Rupert Egensperger; Frauke Neff; Frank Jessen; Julius Popp; Carmen Noelker; Jens Peter Reese; Yousef Al-Abed; Richard Dodel
Journal:  Mol Med       Date:  2010-02-28       Impact factor: 6.354

Review 7.  Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.

Authors:  M J Hofer; I L Campbell
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

8.  Cognitive impairment following high fat diet consumption is associated with brain inflammation.

Authors:  Paul J Pistell; Christopher D Morrison; Sunita Gupta; Alecia G Knight; Jeffrey N Keller; Donald K Ingram; Annadora J Bruce-Keller
Journal:  J Neuroimmunol       Date:  2009-12-08       Impact factor: 3.478

Review 9.  Transgenic models for cytokine-induced neurological disease.

Authors:  Iain L Campbell; Markus J Hofer; Axel Pagenstecher
Journal:  Biochim Biophys Acta       Date:  2009-10-14

10.  Age-related neuroinflammatory changes negatively impact on neuronal function.

Authors:  Marina A Lynch
Journal:  Front Aging Neurosci       Date:  2010-01-04       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.